Table 1.
Scoring system | Cut-off value | Probability of death | Probability of survival | Advantages | Disadvantages |
---|---|---|---|---|---|
Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) | ⩽5 = low risk 6–7 = medium risk ⩾8 = high risk |
– | – | Simple to calculate High positive and negative predictive power |
Not specific to FG Only designed as a diagnostic tool |
Fournier’s Gangrene Severity Index (FGSI) | 9 | 75% | 78% | Incorporates patient factors Regression analysis specific to FG patients |
Timely to calculate |
Uludag Fournier’s Gangrene Severity Index (UFGSI) | 9 | 94% | 81% | Original data based on a larger sample size More sensitive than FGSI |
Timely to calculate Less specific than FGSI |
Simplified Fournier’s Gangrene Severity Index (SFGSI) | 2 | – | – | Only uses three biochemical tests in the calculation | |
Charlson Comorbidity Index | – | – | – | Simple to calculate Widely validated in other disease processes |
Not specific to FG |
Surgical Apgar Score | – | – | – | Simple to calculate Widely validated in other disease processes |
Not specific to FG Calculated from intraoperative parameters therefore limited utility in the initial setting |
Neutrophil-to-lymphocyte ratio (NLR) | – | – | – | A strong predictor of morbidity and mortality in other disease processes | Little research into application in FG patients |
FG, Fournier’s gangrene.